Peripartum Cardiomyopathy From a Genetic Perspective

DOI Web Site Web Site PubMed 被引用文献3件 参考文献45件
  • Kamiya Chizuko A.
    Department of Perinatology and Gynecology, National Cerebral and Cardiovascular Center
  • Yoshimatsu Jun
    Department of Perinatology and Gynecology, National Cerebral and Cardiovascular Center
  • Ikeda Tomoaki
    Department of Obstetrics and Gynecology, Mie University Graduate School of Medicine

この論文をさがす

抄録

<p>Peripartum cardiomyopathy (PPCM) is a rare, but life-threatening condition that occurs during the peripartum period in previously healthy women. Although its etiology remains unknown, potential risk factors include hypertensive disorders during pregnancy, such as preeclampsia, advanced maternal age, multiparity, multiple gestation, and African descent. Several cohort studies of PPCM revealed that the prevalence of these risk factors was quite similar. Clinically, approximately 40% of PPCM patients are complicated with hypertensive disorders during pregnancy. Because PPCM is a diagnosis of exclusion, heterogeneity is a common element in its pathogenesis. Recent genetic research has given us new aspects of the disease. PPCM and dilated cardiomyopathy (DCM) share genetic predisposition: 15% of PPCM patients were found to have genetic mutations that have been associated with DCM, and they showed a lower recovery rate. Other basic research using PPCM model mice suggests that predisposition genes related to both hypertensive and cardiac disorders via angiogenic imbalance may explain common elements of hypertensive disorders and PPCM. Furthermore, hypertensive disorders during pregnancy are now found to be a risk factor of not only PPCM, but also cardiomyopathy in the future. Understanding genetic variations allows us to stratify PPCM patients and to guide therapy. (Circ J 2016; 80: 1684–1688)</p>

収録刊行物

  • Circulation Journal

    Circulation Journal 80 (8), 1684-1688, 2016

    一般社団法人 日本循環器学会

被引用文献 (3)*注記

もっと見る

参考文献 (45)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ